In the United States, approximately *** billion U.S. dollars was spent on medicines in 2022. Nearly ** percent of this figure was spent on generic drugs, with sales of branded generics and unbranded generics accounting for percent and *** percent, respectively.Â
Why are branded drugs more expensive?
Sales of brand name drugs account for some ** percent of the total amount of money spent on medicines in the United States in 2023. One explanation for this large share is that brand name drugs can cost considerably more than generic versions. When a pharmaceutical company is granted a patent for a drug, key processes and active ingredients are protected; this exclusivity allows firms to price a product at what the market will bear. The brand name drug Humira was, and is, marketed at a high price in the United States. Sales of this drug generated around ** billion U.S. dollars per year until 2022.Â
What’s in a name? Knowing your medication types
A brand name drug is manufactured and marketed by a pharmaceutical company that owns the patent. When the patent expires, it is common for generic drugs to enter the market. These are almost identical versions of the brand name drug but are developed by competitors. Generic drugs are often sold under its chemical name but can also be assigned new brand names. If the latter is the case, the drug becomes known as branded generic.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
IQVIA, & Association for Accessible Medicines. (February 6, 2024). Proportion of branded versus generic prescription drug spending in the United States from 2020 to 2023 [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved August 01, 2026, from /statistics/205036/proportion-of-brand-to-generic-prescription-sales/
IQVIA, und Association for Accessible Medicines. "Proportion of branded versus generic prescription drug spending in the United States from 2020 to 2023." Chart. February 6, 2024. ÌÇÐÄÆÆ½â°æ. Accessed August 01, 2026. /statistics/205036/proportion-of-brand-to-generic-prescription-sales/
IQVIA, Association for Accessible Medicines. (2024). Proportion of branded versus generic prescription drug spending in the United States from 2020 to 2023. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: August 01, 2026. /statistics/205036/proportion-of-brand-to-generic-prescription-sales/
IQVIA, and Association for Accessible Medicines. "Proportion of Branded versus Generic Prescription Drug Spending in The United States from 2020 to 2023." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 6 Feb 2024, /statistics/205036/proportion-of-brand-to-generic-prescription-sales/
IQVIA & Association for Accessible Medicines, Proportion of branded versus generic prescription drug spending in the United States from 2020 to 2023 ÌÇÐÄÆÆ½â°æ, /statistics/205036/proportion-of-brand-to-generic-prescription-sales/ (last visited August 01, 2026)
Proportion of branded versus generic prescription drug spending in the United States from 2020 to 2023 [Graph], IQVIA, & Association for Accessible Medicines, February 6, 2024. [Online]. Available: /statistics/205036/proportion-of-brand-to-generic-prescription-sales/